Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tunable single-column deterministic lateral displacement device by adjustable crossflow.

Lab on a chip·2026
Same author

WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.

International journal of radiation oncology, biology, physics·2023
Same author

Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohort.

The Prostate·2023
Same author

Dormant cancer cells: programmed quiescence, senescence, or both?

Cancer metastasis reviews·2023
Same author

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.

EJNMMI research·2022
Same author

Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.

The Prostate·2022

Related Experiment Video

Updated: Jan 5, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.7K

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for

Ke-Chih Lin1, Gonzalo Torga2, Yusha Sun3

  • 1Princeton University; kechihl@princeton.edu.

Journal of Visualized Experiments : Jove
|October 15, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces the "Evolution Accelerator," a microfluidic cancer-on-chip model that simulates tumor microenvironments. It enables real-time monitoring of cancer progression and drug response, offering a more predictive preclinical tool.

More Related Videos

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.0K
A Gradient-generating Microfluidic Device for Cell Biology
11:05

A Gradient-generating Microfluidic Device for Cell Biology

Published on: August 30, 2007

15.8K

Related Experiment Videos

Last Updated: Jan 5, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.7K
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.0K
A Gradient-generating Microfluidic Device for Cell Biology
11:05

A Gradient-generating Microfluidic Device for Cell Biology

Published on: August 30, 2007

15.8K

Area of Science:

  • Oncology
  • Biotechnology
  • Microfluidics

Background:

  • Conventional 2D cell cultures poorly predict clinical cancer outcomes.
  • Animal models present challenges in reproducibility and quantitative analysis.
  • Microfluidic cancer-on-chip models offer a potential solution to bridge this gap.

Purpose of the Study:

  • To develop a microfluidic cancer-on-chip model for comprehensive tumor microenvironment simulation.
  • To enable robust, quantitative analysis of cancer dynamics and drug response.
  • To create a more predictive preclinical model for cancer research.

Main Methods:

  • The
  • Evolution Accelerator
  • model utilizes an interconnected array of microenvironments.
  • It generates a heterogeneous chemotherapeutic stress gradient.
  • Real-time monitoring of cancer cell progression and evolutionary dynamics is enabled.

Main Results:

  • The model successfully reproduces key tumor microenvironment components.
  • It allows for quantitative descriptions of cancer dynamics under drug pressure.
  • Cancer progression and evolutionary dynamics can be monitored for weeks in real time.

Conclusions:

  • The
  • Evolution Accelerator
  • provides a simple yet comprehensive microfluidic platform.
  • It offers robust quantitative insights into cancer evolution and drug response.
  • This model enhances preclinical cancer research by improving predictive accuracy.